Phase II trial of docetaxel in Asian patients with inoperable stage III non-small cell lung cancer

Phase II trial of docetaxel in Asian patients with inoperable stage III non-small cell lung cancer

Acta Oncologica

Saved in:

Bibliographic Details
Main Authors:	Goh, B.C., Lehnert, M., Lim, H.L., Kong, H.L., Lee, S.C., Wong, J.E.L., Ng, A.W.K., Chan, C.C., Wee, J., Chua, E.T.
Other Authors:	MEDICINE
Format:	Article
Published:	2014
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/117805
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Phase II study of concurrent chemoradiotherapy for inoperable (Bulky) stage III (A/B) Non-Small Cell Lung Cancer (NSCLC) : A preliminary report
by: Vorachai Ratanatharathorn, et al.
Published: (2018)

Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: A phase II study in Caucasian and Asian patients
by: Millward, M.J., et al.
Published: (2016)

Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)
by: Nokihara, H, et al.
Published: (2022)

Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: A Cancer Therapeutics Research Group study
by: Soo, R.A., et al.
Published: (2014)

A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours
by: Ang, Y.L.E., et al.
Published: (2021)

Docetaxel as second-line chemotherapy for advanced non-small cell lung cancer
by: Thongprasert S., et al.
Published: (2014)

Phase II study of paclitaxel (Taxol) and ifosfamide (Holoxan) in inoperable non-small-cell lung cancer
by: Thongprasert S.
Published: (2014)

Phase II study of cisplatin combined to irinotecan administered alternatingly with docetaxel in advanced non-small cell lung cancer
by: Charoentum C., et al.
Published: (2014)

A rapid and sensitive liquid chromatography/tandem mass spectrometry method for determination of docetaxel in human plasma
by: Wang, L.Z., et al.
Published: (2012)

Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategies
by: Goh, B.-C., et al.
Published: (2014)

A rapid and sensitive liquid chromatography/tandem mass spectrometry method for determination of docetaxel in human plasma
by: Wang, L.Z., et al.
Published: (2014)

Docetaxel enhances lysosomal function through TFEB activation
by: Zhang J., et al.
Published: (2019)

Cutaneous reaction associated with weekly docetaxel administration
by: Chew, L., et al.
Published: (2014)

Dermal mast cell density and pruritus in end-stage renal failure.
by: Leong, S.O., et al.
Published: (2014)

Endoscopic Nd:YAG laser treatment of inoperable lower gastrointestinal cancer
by: Tai, L.S., et al.
Published: (2016)

PXR, CAR and HNF4α genotypes and their association with pharmacokinetics and pharmacodynamics of docetaxel and doxorubicin in Asian patients
by: Hor, S.Y., et al.
Published: (2014)

PXR, CAR and HNF4α genotypes and their association with pharmacokinetics and pharmacodynamics of docetaxel and doxorubicin in Asian patients
by: Hor, S.Y., et al.
Published: (2011)

A phase I study of docetaxel with ketoconazole modulation in patients with advanced cancers
by: Yong, W.-P., et al.
Published: (2014)

Docetaxel Pharmacogenetics and its Influence on the Pharmacokinetics/Pharmacodynamics of Docetaxel in Asian Nasopharyngeal Cancer Patients
by: CHEW SIN CHI
Published: (2013)

INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer
by: Wu, Y.-L., et al.
Published: (2014)

A phase II study of docetaxel and carboplatin in Thai patients with advanced non-small-cell lung cancer
by: Sumitra Thongprasert, et al.
Published: (2018)

Efficacy of Combination Docetaxel and Nintedanib in Advanced Non-Small Cell Lung Cancer in Thailand: A Multicenter Study
by: Krittiya Korphaisarn, et al.
Published: (2022)

Image-guided high-dose-rate brachytherapy in inoperable endometrial cancer
by: P. Dankulchai, et al.
Published: (2018)

Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma
by: Chalyut Charoentum, et al.
Published: (2018)

Comparison of clinical with pathological nodal staging from systematic mediastinal lymph node dissection in early resectable non-small cell lung cancer
by: Chong, C.F., et al.
Published: (2011)

Gemcitabine and split-dose paclitaxel or docetaxel in metastatic breast cancer: A randomised phase II study
by: Kei Siong Khoo, et al.
Published: (2018)

A phase I/II trial of epirubicin and docetaxel in locally advanced breast cancer (LABC) on 2-weekly or 3-weekly schedules: NCIC CTG MA.22
by: Trudeau, M.E, et al.
Published: (2020)

Multicenter phase II study of sequential radioembolization-sorafenib therapy for inoperable hepatocellular carcinoma
by: Chow, P.K.H., et al.
Published: (2016)

Phase II study of cisplatin combined to irinotecan administered alternatingly with docetaxel in advanced non-small cell lung cancer
by: Chaiyut Charoentum, et al.
Published: (2018)

Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union Against Cancer stage III and IV nasopharyngeal cancer of the endemic variety
by: Wee, J., et al.
Published: (2014)

P-graph approach to allocation of inoperability in urban infrastructure systems
by: Tan, Raymond Girard R., et al.
Published: (2015)

Impact estimation of flooding in Manila: An inoperability input-output approach
by: Yu, Krista Danielle S., et al.
Published: (2013)

A Shock absorption index for inoperability input-output models
by: Tan, Raymond Girard R., et al.
Published: (2015)

Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma
by: Thongprasert S., et al.
Published: (2014)

Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma
by: S. Thongprasert, et al.
Published: (2018)

Safety and tolerability of docetaxel, cyclophosphamide, and trastuzumab compared to standard trastuzumab-based chemotherapy regimens for early-stage human epidermal growth factor receptor 2-positive breast cancer
by: Jitawatanarat,P., et al.
Published: (2015)

Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel
by: Feng, S.-S., et al.
Published: (2014)

A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell lung cancer
by: Soo, R.A., et al.
Published: (2011)

A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell lung cancer
by: Soo, R.A., et al.
Published: (2014)

Nanomedicine: Enhancement of chemotherapeutical efficacy of docetaxel by using a biodegradable nanoparticle formulation
by: Gan, C.W., et al.
Published: (2014)